Lab Anim Res.  2025 Mar;41(1):1-19. 10.1186/s42826-024-00232-4.

Drug screening for ischemic stroke using larvae and adult zebrafish model: a review

Affiliations
  • 1Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Institut Teknologi Bandung, Jl. Ganesha 10, 40132 Bandung, Indonesia
  • 2Department of Natural Medicine, Faculty of Pharmacy, Universitas Mahasaraswati Denpasar, Jl. Kamboja 11A, 80236 Bali, Indonesia
  • 3Physiology, Animal Development, and Biomedical Science Research Group, School of Life Sciences and Technology, Institut Teknologi Bandung, Jl. Ganesha 10, 40132 Bandung, Indonesia

Abstract

Ischemic stroke (IS) is the most recorded case of stroke that is caused by decreased blood flow to the brain. Nowadays, therapeutical agents for IS are limited and they have not shown maximum clinical results. Therefore, the exploration of new candidates for IS treatment continues to be done. Zebrafish as one of the animal models has its advantages and currently is being developed to be incorporated into the drug discovery pipeline of IS. This review explores the latest applications of the zebrafish model in screening potential therapeutic agents for IS. Key factors related to the experimental design such as developmental stage and strain, routes of drug administration, induction methods, and experimental parameters are also elaborated. Finally, this review offers future recommendations for the use of zebrafish in the pre-clinical study of IS. This review is beneficial as a reference for establishing drug screening protocols using the zebrafish IS model.

Keyword

Animal model; Danio rerio; Ischemic stroke; Zebrafish
Full Text Links
  • LAR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr